|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 104, Issue 2 307-315, Copyright © 1993 by Company of Biologists
JOURNAL ARTICLES |
AC Bayly, NJ French, C Dive and RA Roberts
Molecular Pharmacology and Toxicology Laboratory, School of Biological Sciences, University of Manchester, England.
A range of hepatoma cell lines (RH1, HTC, FaO, 7800C1 and MH1C1), has been studied with the aim of establishing an in vitro model to investigate the molecular mechanisms of hepatocarcinogenicity induced by the peroxisome proliferator class of non-genotoxic carcinogens. In view of speculation that peroxisome proliferators suppress hepatocyte apoptosis in vivo, we have placed particular emphasis on evaluating whether hepatoma cell lines retain the ability to undergo apoptotic cell death. Expression of the liver-specific differentiation marker albumin and the peroxisome proliferator-activated receptor (PPAR) was highest in the Reuber hepatoma cell line, FaO. This cell line also demonstrated the most marked response to the peroxisome proliferator nafenopin with a 2.2-fold induction of the microsomal enzyme cytochrome p450IVA1. This response was found to display intercellular heterogeneity by immunocytochemistry. Thus, the FaO cell line maintained characteristics of hepatocytes, both in vivo and in vitro, in terms of expression of constitutive and inducible markers. However, none of the cell lines tested mirrored the hyperplastic response of hepatocytes to nafenopin, since no increase in cell growth kinetics was observed on addition of nafenopin to the growth medium. The mode of cell death in confluent FaO cultures was characterised as apoptosis, by fluorescence microscopy and agarose gel electrophoresis of extracted DNA. Cells detaching from confluent FaO cultures exhibited chromatin condensation and DNA fragmentation patterns characteristic of cels undergoing apoptotic death.Interestingly, no apoptosis was seen in monolayer cells, suggesting that apoptosis in vitro is associated with cell shrinkage and detachment similar to that documented for the liver in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  H. P. Glauert, A. Eyigor, J. C. Tharappel, S. Cooper, E. Y. Lee, and B. T. Spear Inhibition of Hepatocarcinogenesis by the Deletion of the p50 Subunit of NF-{kappa}B in Mice Administered the Peroxisome Proliferator Wy-14,643 Toxicol. Sci., April 1, 2006; 90(2): 331 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Shipley, C. H. Hurst, S. S. Tanaka, F. L. DeRoos, J. L. Butenhoff, A. M. Seacat, and D. J. Waxman trans-Activation of PPAR{alpha} and Induction of PPAR{alpha} Target Genes by Perfluorooctane-Based Chemicals Toxicol. Sci., July 1, 2004; 80(1): 151 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Tharappel, A. Nalca, A. B. Owens, L. Ghabrial, E. C. Konz, H. P. Glauert, and B. T. Spear Cell Proliferation and Apoptosis Are Altered in Mice Deficient in the NF-{kappa}B p50 Subunit after Treatment with the Peroxisome Proliferator Ciprofibrate Toxicol. Sci., October 1, 2003; 75(2): 300 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Goll, C Viollon-Abadie, L Nicod, and L Richert Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines Human and Experimental Toxicology, March 1, 2000; 19(3): 193 - 202. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Y. Moya-Camarena, J. P. V. Heuvel, S. G. Blanchard, L. A. Leesnitzer, and M. A. Belury Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR{alpha} J. Lipid Res., August 1, 1999; 40(8): 1426 - 1433. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Chevalier and R.A. Roberts G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent non-genotoxic hepatocarcinogen nafenopin Carcinogenesis, July 1, 1999; 20(7): 1209 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-I. Ohtani, H. Shimizu, N. Sato, and M. Mori Troglitazone (CS-045) Inhibits {beta}-Cell Proliferation Rate Following Stimulation of Insulin Secretion in HIT-T 15 Cells Endocrinology, January 1, 1998; 139(1): 172 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Ledwith, C. J. Pauley, L. K. Wagner, C. L. Rokos, D. W. Alberts, and S. Manam Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver Cells J. Biol. Chem., February 7, 1997; 272(6): 3707 - 3714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pullan, J. Wilson, A. Metcalfe, G. M. Edwards, N. Goberdhan, J. Tilly, J. A. Hickman, C. Dive, and C. H. Streuli Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium J. Cell Sci., March 1, 1996; 109(3): 631 - 642. [Abstract] [PDF]
|
|
